Jurnal Reading HF

You might also like

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 34

Journal Reading

Nazdifatu Zulfa (01.211.6467)

Pembimbing :

dr. Rino A.M, Sp.PD


Disclosures

I have nothing to disclose.


New aspects

1. Definition
2. Types of HF: HFrEF, HFmrEF, HFpEF
3. Algorithms in chronic and acute heart
failure
4. Valsartan/sacubitril
5. Modified CRT indications
6. Focus on comorbidities
Definition of HF
Type and diagnosis of HF
Diagnostic algorithm (non-acute onset)
Initial work-up after diagnosis
Treatment of HFrEF
Background on
valsartan/sacubitril
PARADIGM-HF Trial
Guidance on valsartan/sacubitril
Treatment of HFrEF
Treatment of HFrEF
Recommendations on ICD
Recommendations on CRT
Recommendations on CRT
EchoCRT Trial IPD meta-analysis of five RCTs
Treatment of HFmrEF and
HFpEF
Comorbidities: Iron, Diabetes,
CSA, Arthritis
Comorbidities: CKD
Comorbidities: COPD
Comorbidities: Obesity
Acute heart failure: Initial
Assessment
Acute heart failure: Algorithms
Cont.....
Acute heart failure: Treatment
Acute heart failure: Treatment
Exercise and (tele-)monitoring
programs
Prevention of HF
Conclusions

New guidelines: Consistent incorporation of last 4 years evidence


HF with mid-range EF (40-49%) New subtype to boost research efforts
Valsartan/Sacubitril: Use when symptomatic on optimal ACEI, BB and MRA
CRT: Contraindicated in QRS duration <130ms
HFpEF/HFmrEF: Lack of treatments, focus on symptoms and comorbidities
Acute HF: Congestion/perfusion assessment to triage treatment, effective
therapies still lacking
New recommendations on comorbidities (i.e. iron, diabetes, ASV)
Strong recommendations for exercise in HF patients
Prevention of HF in diabetic patients: consider empagliflozin

You might also like